Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
SK Life Science Logo
SK Life Science CB Rank
170934
Heat Score
71
SK life science is committed to developing innovative treatments for central nervous system disorders.
Founded
obfuscation
Private Paramus, New Jersey, United States101-250 www.sklifescienceinc.com/
Biotechnology
Pharmaceutical
Overview

SK Life Science
Heat Score
71

Growth Score
pts
in past quarter
Heat Score 71
20 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+2 more milestones
See more interactive data and historical milestones on desktop for the best experience

About SK Life Science

CB Rank
170934
SK life science is committed to developing innovative treatments for central nervous system disorders.
Founded
obfuscation
Private Paramus, New Jersey, United States101-250 www.sklifescienceinc.com/
Biotechnology
Pharmaceutical

Key People

Details

Legal Name SK Life Science
Operating Status Active
Company Type For Profit
Founders  Jeong Woo Cho
Phone Number 1-866- (657-5574)
Contact Email Info@SKLSI.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Awards

Products & Services

XCOPRI® (cenobamate tablets) CV
An oral medication approved for the treatment of focal (partial-onset) seizures in epilepsy patients.
Carisbamate
A drug candidate under clinical development for the treatment of Lennox-Gastaut Syndrome, a severe childhood-onset epilepsy.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 101-250 Employee Profiles 2

Employee Profiles

News

News and Press

News•Jun 15, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 15, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 8, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 16, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

3,349
190.96%
 in past month

Interest Signals

TopicSurge Score
Streaming Media Logo
Streaming Media
100
Security Monitoring Logo
Security Monitoring
98
Trade Spend Optimization Logo
Trade Spend Optimization
96

Active Website Tech Count

24SK Life Science is actively using 24 technologies for its website, according to BuiltWith. These include Common Crawl, DNSSEC, and  nginx.
Sub-Organizations
Frequently Asked Questions

Where is SK Life Science's headquarters? SK Life Science is located in Paramus, New Jersey, United States.Who are SK Life Science's competitors? Alternatives and possible competitors to SK Life Science may include Takeda, Lundbeck, and  Jazz Pharmaceuticals.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3ccf175 1)
|